Shandong Xinhua Pharmaceutical Co Ltd

00719

Company Profile

  • Business description

    Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs which also generates key revenue, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics. Geographically, the company generates a majority of its revenue from China (including Hong Kong), America, Europe and others.

  • Contact

    No. 1 Lutai Avenue
    Hi-tech Industry Development Zone
    ZiboShandong255086
    CHN

    T: +86 5332166666

    http://www.xhzy.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2024

    Employees

    7,064

Stocks News & Analysis

stocks

Best and worst performing ASX sectors of 2024

Exploring the ASX sectors that moved the market this year.
stocks

2 ASX companies with the traits of a long-term winner

Two companies that show promising signs of handsomely rewarding shareholders.
video

Our outlook for 2025

Morningstar Equity Market Strategist Lochlan Halloway discusses his view on what we can expect in markets in 2025. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,471.5018.800.22%
CAC 407,282.6910.370.14%
DAX 4019,848.7735.98-0.18%
Dow JONES (US)43,297.03390.080.91%
FTSE 1008,136.9934.270.42%
HKSE20,098.29215.161.08%
NASDAQ20,031.13266.241.35%
Nikkei 22539,568.06437.631.12%
NZX 50 Index13,074.7486.710.67%
S&P 5006,040.0465.971.10%
S&P/ASX 2008,220.9019.300.24%
SSE Composite Index3,393.5342.271.26%

Market Movers